SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-Feb-23 9:00 AM View: | Nile Therapeutics, Inc (CAPR) | 21-Feb-23 | Disposition | 452 | $4.31 | $1,948.12 | (< 1%) 62.6K to 62.15K | |
23-Feb-23 9:00 AM View: | Nile Therapeutics, Inc (CAPR) | 21-Feb-23 | Option Exercise | 1,401 | $1.39 | $1,947.39 | 2% 61.2K to 62.6K | |
01-Apr-22 5:00 PM View: | Nile Therapeutics, Inc (CAPR) | 31-Mar-22 | Payment of Exercise | 11,309 | $3.43 | $38,789.90 | (41%) 27.9K to 16.59K | |
01-Apr-22 5:00 PM View: | Nile Therapeutics, Inc (CAPR) | 31-Mar-22 | Option Exercise | 27,904 | $1.39 | $38,786.60 | 100% 0 to 27.9K | |
28-Sep-20 8:30 AM View: | Nile Therapeutics, Inc (CAPR) | 24-Sep-20 | Option Exercise | 8,299 | $3.70 | $30,706.30 | 8% 100.12K to 108.42K | (2%) |
19-Dec-19 7:34 PM View: | Nile Therapeutics, Inc (CAPR) | 17-Dec-19 | Grant | 20,391 | -- | -- | 26% 79.73K to 100.12K | |
25-Oct-17 12:00 PM View: | Nile Therapeutics, Inc (CAPR) | 23-Oct-17 | Option Exercise | 20,748 | $0.16 | $3,319.68 | 3% 776.54K to 797.29K | |
11-May-17 2:31 PM View: | Nile Therapeutics, Inc (CAPR) | 09-May-17 | Market Purchase | 10,000 | $3.10 | $31,000.00 | 1% 766.54K to 776.54K | (87%) |
18-Mar-16 9:31 PM View: | Nile Therapeutics, Inc (CAPR) | 16-Mar-16 | Market Purchase | 100,000 | $2.40 | $240,000.00 | 15% 666.54K to 766.54K | (83%) |
22-Jan-15 7:39 PM View: | Nile Therapeutics, Inc (CAPR) | 21-Jan-15 | Private Purchase | 28,384 | $3.52 | $99,996.80 | 4% 638.15K to 666.54K |